Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vagus Nerve Stimulation to Promote Remyelination in Multiple Sclerosis

NCT06641271 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT06641271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vagus Nerve Stimulation to Promote Remyelination in Multiple Sclerosis
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 21, 2025
Completion date
July 31, 2031
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis (ms) - relapsing-remitting